Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Arunkumar Modi"'
Publikováno v:
Transplantation and Cellular Therapy. 29:S366-S367
Autor:
David S. Dickens, Alexa Warmoth, Ethan Pottebaum, Michael H. Tomasson, Melissa L. Bates, Yogesh Jethava, Sabarish Ayyappan, Lucas J. Carr, Arunkumar Modi
Publikováno v:
Exercise and Sport Sciences Reviews. 49:205-212
Hematopoietic stem cell transplant (HSCT) is a potentially curative treatment for hematopoietic malignancies, complicated by decreased performance status and quality of life. Exercise therapy improves outcomes in HSCT, but several barriers have preve
Autor:
Richard C Godby, Asmaa Ferdjallah, Hassan B. Alkhateeb, Victor Aquino, Michelle Hudspeth, Hemalatha G. Rangarajan, Carrie L. Kitko, Eric Anderson, Susan Kelly, Dr. Arunkumar Modi, Emmanuel Katsanis, Shanti Ramachandran, Yi Lin, Mira Kohorst
Publikováno v:
Blood. 140:12762-12763
Autor:
Klaus Warnatz, Kohsuke Imai, Bénédicte Neven, Mette Holm, Ulrich Duffner, B Carpenter, Musa Karakukcu, Hassan Abolhassani, Robert Wynn, Neena Kapoor, Jennifer A. Kanakry, Marina Garcia-Prat, Mariacristina Menconi, Anna Mukhina, Pere Soler-Palacín, Takahiro Tomoda, Claudia Wehr, Diana K. Bayer, Eleonora Gambineri, Gulbu Uzel, Austen Worth, Arunkumar Modi, Mary Slatter, Tania Nicole Masmas, Dimana Dimitrova, Carsten Speckmann, J.J. Bleesing, Shankara Paneesha, Kanchan Rao, Sylwia Kołtan, Carmem Bonfim, Jasmeen Dara, Colin G. Steward, Winnie Ip, Emma C. Morris, Asghar Aghamohammadi, Andrew R. Gennery, Gašper Markelj, Luigi D. Notarangelo, Stephen M. Hughes, Sujal Ghosh, Tsubasa Okano, Ansgar Schulz, Arjan C. Lankester, Stephen Jolles, Ebru Yilmaz, Alexandra Laberko, Maria Elena Maccari, Stephan Ehl, Christopher C. Dvorak, Despina Moshous, Hyoung Jin Kang, Carolina Prando, Zohreh Nademi
Publikováno v:
Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', Journal of Allergy and Clinical Immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036
The Journal of allergy and clinical immunology, vol 149, iss 1
Journal of Allergy and Clinical Immunology, 149(1), 410-421. MOSBY-ELSEVIER
The Journal of allergy and clinical immunology
Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', The Journal of allergy and clinical immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036
Scientia
The Journal of allergy and clinical immunology, vol 149, iss 1
Journal of Allergy and Clinical Immunology, 149(1), 410-421. MOSBY-ELSEVIER
The Journal of allergy and clinical immunology
Dimitrova, D, Nademi, Z, Maccari, M E, Ehl, S, Uzel, G, Tomoda, T, Okano, T, Imai, K, Carpenter, B, Ip, W, Rao, K, Worth, A J J, Laberko, A, Mukhina, A, Néven, B, Moshous, D, Speckmann, C, Warnatz, K, Wehr, C, Abolhassani, H, Aghamohammadi, A, Bleesing, J J, Dara, J, Dvorak, C C, Ghosh, S, Kang, H J, Markelj, G, Modi, A, Bayer, D K, Notarangelo, L D, Schulz, A, Garcia-Prat, M, Soler-Palacín, P, Karakükcü, M, Yilmaz, E, Gambineri, E, Menconi, M, Masmas, T N, Holm, M, Bonfim, C, Prando, C, Hughes, S, Jolles, S, Morris, E C, Kapoor, N, Koltan, S, Paneesha, S, Steward, C, Wynn, R, Duffner, U, Gennery, A R, Lankester, A C, Slatter, M & Kanakry, J A 2022, ' International retrospective study of allogeneic hematopoietic cell transplantation for activated PI3K-delta syndrome ', The Journal of allergy and clinical immunology, vol. 149, no. 1, pp. 410-421.e7 . https://doi.org/10.1016/j.jaci.2021.04.036
Scientia
Immunodeficiència primària; Limfoproliferació; Inhibidor de mTOR Inmunodeficiencia primaria; Linfoproliferación; Inhibidor de mTOR Primary immunodeficiency; Lymphoproliferation; MTOR inhibitor Background Activated phosphoinositide 3-kinase delta
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fff24621d0b56e0aaf43e9d30b95d29e
https://hdl.handle.net/1887/3277790
https://hdl.handle.net/1887/3277790
Publikováno v:
J Pediatr Hematol Oncol
Background Cytarabine is a nucleoside analog used in chemotherapy regimens for the treatment of multiple hematologic malignancies. One of the known adverse effects of cytarabine, particularly in patients receiving high-dose cytarabine (HDAC), is drug
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e66cd0738a36e70cc6c2f8ca61705d36
https://europepmc.org/articles/PMC8329102/
https://europepmc.org/articles/PMC8329102/
Autor:
Erin E. Reasoner, Hend M. Al-Kaylani, Amy L. Conrad, Susan Madasu, Arunkumar Modi, Sarah L. Mott, Ellen van der Plas, Audrey Liu, David S. Dickens, Lyndsay A. Harshman, Bradley T. Loeffler, Amanda Grafft, Kathleen Langbehn
Publikováno v:
Cancer Reports. 5
BACKGROUND Recent shifts from radiation to chemotherapy-based treatment for acute lymphoblastic leukemia (ALL) have contributed to reduced long-term morbidity. Despite this, ALL survivors remain at increased risk for long-term cognitive impairments.
Autor:
Hemalatha G. Rangarajan, Joseph R. Stanek, Hisham Abdel-Azim, Arunkumar Modi, Ann Haight, Christopher M. McKinney, Daniel J. McKeone, David K. Buchbinder, Emmanuel Katsanis, Ghada A. Abusin, Ibrahim Ahmed, Jason Law, Jorge Galvez Silva, Kanwaldeep K. Mallhi, Lauri M. Burroughs, Niketa Shah, Peter J. Shaw, Robert Greiner, Shalini Shenoy, Michael A. Pulsipher, Rolla Abu-Arja
Publikováno v:
Transplantation and Cellular Therapy. 28:329.e1-329.e9
Hematopoietic cell transplantation (HCT) is the sole curative option for congenital dyserythropoietic anemia (CDA), a rare type of hemolytic anemia characterized by anemia, ineffective erythropoiesis, and secondary hemochromatosis. In this retrospect
Autor:
Emmanuel Katsanis, Arunkumar Modi, Hemalatha G. Rangarajan, Kanwaldeep K. Mallhi, Ibrahim Ahmed, Joseph Stanek, Daniel J. McKeone, Ghada Abusin, Robert J. Greiner, Ann E. Haight, Shalini Shenoy, Lauri S Burroughs, Jorge Galvez Silva, David Buchbinder, Jason Law, Rolla Abu-Arja, Peter J. Shaw, Christopher M. McKinney, Michael A. Pulsipher, Hisham Abdel-Azim
Publikováno v:
Blood. 136:42-43
Introduction Congenital dyserythropoietic anemias (CDA) are a rare group of hereditary disorders characterized by anemia, ineffective erythropoiesis, and secondary hemochromatosis. While some CDA patients respond to interferon α therapy (type I CDA)
Autor:
Ebru Yilmaz, Alexandra Laberko, Arjan C. Lankester, Zohreh Nademi, Claudia Wehr, Hyoung Jin Kang, Maria Elena Maccari, Anna Mukhina, Hassan Abolhassani, Pere Soler-Palacín, Ansgar Schulz, Jennifer A. Kanakry, Marina Garcia-Prat, Mary Slatter, Jack J. Bleesing, Christopher C. Dvorak, Musa Kurakukcu, Kanchan Rao, Winnie Ip, Dimana Dimitrova, Jasmeen Dara, Asghar Aghamohammadi, Andrew R. Gennery, Carsten Speckmann, Gašper Markelj, Luigi D. Notarangelo, Sujal Ghosh, Diana K. Bayer, Gulbu Uzel, Arunkumar Modi, Stephan Ehl, Austen Worth
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S14-S15
Mutations resulting in increased PI3K signaling confer increased risk of B cell lymphoma, recurrent infections, poor viral control, and autoimmunity. Allogeneic HCT is curative, but the optimal approach to HCT for these patients is still evolving as
Autor:
Arunkumar Modi, Paula McCue, Jason Cleppe, Christopher Rokes, Elizabeth Amelon, Anjali Sharathkumar, Stephen Rumelhart
Publikováno v:
Biology of Blood and Marrow Transplantation. 26:S213
Sickle cell disease can be cured with allogeneic HSCT. However, graft rejection and treatment related morbidity remains an obstacle in treating these patients with HSCT. Consequently, the intensity of the preparative regimen is crucial in establishin